V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330004283 | 330002099 | 1.89 | 68.9 | Disease modification (D) | 2015-03-07 | 2015-03-07 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330017048 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330004284 | 330002099 | 1.63 | 85 | Adjuvant (A) | 2018-03-10 | 2018-03-18 | GEMCARBO | N | N | 330017048 | GEMCARBO |
| 330004285 | 330002099 | 1.75 | 96.4 | Neo-adjuvant (N) | 2014-06-12 | 2014-06-12 | CAP | 2 | N | 330017048 | CAP |
| 330004286 | 330002100 | 1.33 | null | Neo-adjuvant (N) | 2013-04-21 | 2013-05-05 | EW EuroEwing 2012 Arm A VIDE | N | Y | 330017057 | EURO-EWING |
| 330004289 | 330002102 | null | 68.4 | Curative (C) | 2016-12-28 | 2017-01-02 | EW EuroEwing 99 : VIDE | N | N | 330017083 | EURO-EWING |
| 330004290 | 330002103 | null | 76.3 | Neo-adjuvant (N) | 2016-10-17 | 2016-10-17 | EW EuroEwing 99 : VIDE | N | N | 330017085 | EURO-EWING |
| 330004291 | 330007151 | 1.62 | 79.3 | Palliative (P) | 2013-09-12 | 2013-09-17 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 330017086 | CISPLATIN + GEMCITABINE |
| 330004292 | 330002104 | 1.84 | 99.9 | Palliative (P) | 2014-01-10 | 2014-01-10 | Cisplatin + Etoposide (3 day) | N | N | 330017087 | CISPLATIN + ETOPOSIDE |
| 330004293 | 330007152 | 0 | 72.7 | Palliative (P) | 2013-03-01 | 2013-03-17 | CAP | N | N | 330017088 | CAP |
| 330004294 | 330007152 | 1.79 | null | Curative (C) | 2015-05-03 | 2015-05-05 | Dox + HD Mtx (post PAM) | 2 | N | 330017088 | DOXORUBICIN + HD MTX |
| 330004295 | 330007152 | 1.74 | 68.3 | Palliative (P) | 2017-08-03 | 2017-08-14 | CISPLATIN + GEMCITABINE | 2 | N | 330017088 | CISPLATIN + GEMCITABINE |
| 330004296 | 330012219 | 1.84 | 77.5 | Curative (C) | 2015-09-22 | 2015-09-27 | OST Euramos 1 Closed Trial - AP | Y | N | 330017104 | MAP |
| 330004297 | 330012219 | 1.6 | 53 | Neo-adjuvant (N) | 2013-07-04 | 2013-07-16 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 330017104 | CISPLATIN + GEMCITABINE |
| 330004298 | 330002105 | null | 58.3 | Neo-adjuvant (N) | 2013-08-30 | 2013-08-30 | EW EuroEwing 2012 Arm A VIDE | 2 | N | 330017115 | EURO-EWING |
| 330004299 | 330002105 | 1.84 | 101 | Neo-adjuvant (N) | 2015-09-20 | 2015-09-25 | EW EuroEwing 2012 Arm A VIDE | N | N | 330017115 | EURO-EWING |
| 330004300 | 330002105 | 1.66 | 85 | Curative (C) | 2016-12-17 | 2016-12-17 | DA | 2 | N | 330017115 | DA |
| 330004301 | 330002106 | 1.63 | 62.5 | Neo-adjuvant (N) | 2013-09-16 | 2013-09-18 | Dox + HD Mtx (post PAM) | null | null | 330017122 | DOXORUBICIN + HD MTX |
| 330004302 | 330002107 | 1.57 | 48 | Palliative (P) | 2013-05-23 | 2013-05-23 | EW EuroEwing 2012 Arm A VIDE | N | N | 330017130 | EURO-EWING |
| 330004303 | 330002107 | null | 85.9 | null | 2014-09-16 | 2014-09-28 | CARBO + FLUOROURACIL | null | N | 330017130 | CARBO + FLUOROURACIL |
| 330004304 | 330002108 | 1.7 | 75.9 | Neo-adjuvant (N) | 2016-08-19 | 2016-08-20 | Cisplatin + Etoposide (3 day) | 02 | N | 330017148 | CISPLATIN + ETOPOSIDE |
| 330004305 | 330007155 | 1.77 | null | null | null | 2016-07-17 | DA 3 + 10 | null | N | 330017159 | DA |
| 330004306 | 330007155 | 1.76 | 91.5 | Disease modification (D) | 2014-12-30 | 2015-01-28 | Cyclophosphamide + Dex + Rituximab | N | N | 330017159 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330004307 | 330002109 | 1.56 | 9.2 | Palliative (P) | 2017-07-27 | 2017-08-03 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 330017168 | CARBO + FLUOROURACIL |
| 330004308 | 330002109 | 1.68 | 99.9 | Not known (9) | 2016-01-06 | 2016-01-06 | EURAMOS TRIAL | 2 | null | 330017168 | EURAMOS TRIAL |
| 330004309 | 330002109 | null | null | Curative (C) | 2016-11-22 | 2016-11-24 | Cetuximab 7 day (Cycle 1) | null | N | 330017168 | CETUXIMAB |
| 330004310 | 330002110 | 1.75 | 84.1 | Not known (9) | 2016-12-16 | 2016-12-24 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 330017199 | CISPLATIN + GEMCITABINE |
| 330004311 | 330002111 | 1.67 | 77.7 | Neo-adjuvant (N) | 2015-06-18 | 2015-06-25 | CAP | 02 | N | 330017201 | CAP |
| 330004312 | 330002111 | null | 62 | Curative (C) | null | 2016-02-11 | EP 1 2 or 3 day | N | N | 330017201 | CISPLATIN + ETOPOSIDE |
| 330004313 | 330002111 | 1.8 | 136.5 | Palliative (P) | 2015-10-02 | 2015-10-16 | CAP | N | N | 330017201 | CAP |
| 330004314 | 330002111 | 1.69 | 48 | Curative (C) | 2016-04-24 | 2016-04-25 | CETUXIMAB + RT | N | N | 330017201 | CETUXIMAB + RT |
| 330004315 | 330002112 | 1.65 | 67 | Neo-adjuvant (N) | 2014-01-08 | 2014-01-21 | Carbo F | N | N | 330017214 | CARBO + FLUOROURACIL |
| 330004316 | 330007158 | 1.54 | 66 | Not known (9) | 2013-08-12 | 2013-08-19 | Cetuximab + Radiotherapy Maint | 02 | N | 330017215 | CETUXIMAB + RT |
| 330004317 | 330007158 | 1.74 | null | Curative (C) | 2013-03-21 | 2013-03-28 | EW EuroEwing 99 : VIDE | N | N | 330017215 | EURO-EWING |
| 330004318 | 330011395 | null | 57.4 | Neo-adjuvant (N) | 2015-05-12 | 2015-05-18 | CISPLATIN + ETOPOSIDE | N | N | 330017228 | CISPLATIN + ETOPOSIDE |
| 330004319 | 330011395 | null | null | Not known (9) | 2013-04-03 | 2013-04-08 | DA 3 + 10 | N | N | 330017228 | DA |
| 330004320 | 330002113 | 1.57 | 73.1 | Palliative (P) | 2013-02-26 | 2013-03-05 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 330017243 | CISPLATIN + GEMCITABINE |
| 330004321 | 330002114 | 1.62 | 75.6 | Curative (C) | 2016-09-07 | 2017-08-18 | EW EuroEwing 2012 Arm A VIDE | 2 | N | 330017251 | EURO-EWING |
| 330004322 | 330002115 | 1.66 | 78 | null | 2017-02-04 | 2017-02-04 | CETUXIMAB + RT | 02 | null | 330017258 | CETUXIMAB + RT |
| 330004324 | 330002116 | 1.63 | 91.2 | Palliative (P) | 2014-05-28 | 2014-05-29 | GemCarbo Days 1+8 | 2 | N | 330017260 | GEMCARBO |
| 330004325 | 330002117 | null | null | Palliative (P) | 2017-01-09 | 2017-01-09 | Cisplatin + Etoposide (3 day) | N | N | 330017265 | CISPLATIN + ETOPOSIDE |
| 330004326 | 330002117 | 1.72 | 69.4 | Curative (C) | 2017-08-22 | 2017-08-22 | DA 3 + 10 | N | null | 330017265 | DA |
| 330004328 | 330007161 | 1.68 | 58 | Curative (C) | 2016-01-07 | 2016-01-08 | CISPLATIN + ETOPOSIDE | 2 | N | 330017292 | CISPLATIN + ETOPOSIDE |
| 330004329 | 330002119 | 1.72 | null | Palliative (P) | 2015-05-23 | 2015-05-31 | Cyclophosphamide + Dex + Rituximab | N | N | 330017295 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330004330 | 330007162 | 1.73 | 64.6 | Curative (C) | 2013-12-19 | 2013-12-19 | Cetuximab + Radiotherapy Maint | 02 | N | 330017304 | CETUXIMAB + RT |
| 330004331 | 330009882 | 1.87 | 83.9 | Neo-adjuvant (N) | null | 2015-07-12 | Dox + HD Mtx (post PAM) | N | N | 330017305 | DOXORUBICIN + HD MTX |
| 330004332 | 330002120 | 0 | 41.4 | Neo-adjuvant (N) | 2016-05-04 | 2016-05-04 | EW EuroEwing 99 : VIDE | Y | N | 330017306 | EURO-EWING |
| 330004333 | 330002120 | 0 | 62.6 | Palliative (P) | 2017-12-13 | 2017-12-22 | CAP | 02 | N | 330017306 | CAP |
| 330004334 | 330002120 | 1.82 | 74.9 | Palliative (P) | 2014-03-12 | 2014-04-12 | Cyclophosphamide + Dex + Rituximab | null | Y | 330017306 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330004335 | 330002120 | 1.86 | null | Neo-adjuvant (N) | 2014-04-22 | 2014-04-27 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330017306 | CARBO + FLUOROURACIL |
| 330004338 | 330002121 | 1.7 | 52.7 | Palliative (P) | 2016-06-13 | 2016-06-24 | VAC | 02 | N | 330017338 | MITOTANE |